Myrislignan
CAS: 171485-39-5
Ref. 3D-FM73790
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado |
Información del producto
Nombre:
Myrislignan
Sinónimos:
- (aR)-alpha-[(1S)-1-[2,6-Dimethoxy-4-(2-propen-1-yl)phenoxy]ethyl]-4-hydroxy-3-methoxybenzenemethanol
Descripción:
Myrislignan is a natural compound that belongs to the group of epidermal growth factor (EGF) and has been shown to have potent cytotoxicity in many types of cancer cells. Myrislignan also induces pro-apoptotic protein expression and mitochondrial membrane potential reduction, which leads to cell death. Myrislignan is synthesized from a fatty acid by an asymmetric synthesis, which can be achieved through an intramolecular hydrogen transfer. This process creates two molecules of myrislignan, one with a hydroxyl group on carbon 2 and the other with a hydroxyl group on carbon 3. The pharmacokinetic properties of myrislignan are not well understood but it has been shown to bind to rat liver microsomes.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
374.43 g/mol
Fórmula:
C21H26O6
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
